Virtual Medicinal Product (VMP)
-
Tocilizumab 400mg/20ml solution for infusion vials
Name Details
Current Name
Tocilizumab 400mg/20ml solution for infusion vials
|
Start Date
01-10-2009
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 20.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L04AC07
BNF |
Current BNF
10010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
10010300
|
Start Date
11-05-2010
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
16102011000001108 |
01-10-2009 |
|
VMP Ingredients
VMP ingredients table
Tocilizumab |
Based on Ingredient Substance |
|
20 mg |
1 ml |
Name
Tocilizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Tocilizumab
-
VMP
(Current) Tocilizumab 400mg/20ml solution for ...
Virtual Medicinal Product Pack (VMPP) Information